oxidopamine has been researched along with Shock in 2 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tong, J | 1 |
| Baines, AD | 1 |
| Tabsh, K | 1 |
| Rudelstorfer, R | 1 |
| Nuwayhid, B | 1 |
| Assali, NS | 1 |
2 other studies available for oxidopamine and Shock
| Article | Year |
|---|---|
In patients receiving dopamine infusions for treatment of shock do free radicals convert dopamine to 6-hydroxydopamine?
Topics: Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Dopamine; Free Radicals; Humans; | 1993 |
Circulatory responses to hypovolemia in the pregnant and nonpregnant sheep after pharmacologic sympathectomy.
Topics: Adrenal Medulla; Animals; Blood Circulation; Blood Pressure; Catecholamines; Female; Heart Rate; Hom | 1986 |